Gujarat Kidney and Super Speciality Share Price

Healthcare Facilities company Gujarat Kidney and Super Speciality announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: In Q4FY26, revenue was Rs 3,057.85 lakh, an increase of 31.54% from Rs 2,324.59 lakh in Q3FY26 and up 212.59% from Rs 978.23 lakh in Q4FY25. For the full year FY26, revenue surged to Rs 8,201.34 lakh from Rs 4,024.21 lakh in FY25. Total Income: Total income for Q4FY26 was Rs 3,129.17 lakh, up 34.25% QoQ from Rs 2,330.91 lakh and up 218.23% YoY from Rs 983.32 lakh. For the full year FY26, total income stood at Rs 8,288.60 lakh compared to Rs 4,039.70 lakh in FY25. Profit Before Tax (PBT): For Q4FY26, PBT stood at Rs 502.92 lakh, up 7.33% QoQ from Rs 468.58 lakh and up 213.56% YoY from Rs 160.39 lakh. Annual PBT grew by 66.35% to Rs 2,123.47 lakh in FY26 from Rs 1,276.52 lakh in FY25. Net Profit Attributable to Owners: Net profit for Q4FY26 was Rs 504.19 lakh, up 71.41% from Rs 294.15 lakh in Q3FY26 and up 294.64% from Rs 127.76 lakh in Q4FY25. For the full year FY26, it reached Rs 1,549.69 lakh against Rs 941.31 lakh in FY25. Earnings Per Share (EPS): Basic and diluted EPS for FY26 stood at Rs 2.49, up from Rs 1.85 in FY25. Standalone Financial Highlights: Revenue from Operations: For Q4FY26, revenue stood at Rs 924.32 lakh, a decrease of 5.34% compared to Rs 976.45 lakh in Q3FY26, and an increase of 15.31% compared to Rs 801.62 lakh in Q4FY25. For the full year FY26, revenue was Rs 4,010.02 lakh, up 14.03% from Rs 3,516.70 lakh in FY25. Total Income: The total income for Q4FY26 reached Rs 969.38 lakh, down 1.00% sequentially from Rs 979.18 lakh in Q3FY26 and up 20.31% from Rs 805.73 lakh in Q4FY25. For FY26, total income stood at Rs 4,059.47 lakh against Rs 3,528.11 lakh in FY25. Profit Before Tax (PBT): For Q4FY26, PBT was Rs 85.72 lakh, down 72.90% from Rs 316.29 lakh in Q3FY26 and down 41.84% from Rs 147.38 lakh in Q4FY25. For the full year FY26, PBT grew by 3.72% to Rs 1,254.70 lakh from Rs 1,209.67 lakh in FY25. Net Profit: The standalone net profit for Q4FY26 was Rs 136.78 lakh, compared to Rs 233.26 lakh in Q3FY26 and Rs 126.48 lakh in Q4FY25. For the full year FY26, net profit grew by 8.70% to Rs 990.14 lakh from Rs 910.90 lakh in FY25. Earnings Per Share (EPS): Basic and diluted EPS for FY26 was Rs 1.59, compared to Rs 1.79 in FY25. Business Highlights: Segment Performance: The company’s business activity falls within a single primary business segment (Healthcare services), and therefore, the disclosure requirements as per Ind-AS 108 “operating segments” are not applicable. Appointment of CEO: The Board has deferred the agenda for the appointment of the CEO. Postal Ballot: The company will conduct a postal ballot to seek shareholder approval by way of a Special Resolution for the variation in the objects of the IPO. Auditor Appointments: Mr. Siddharth Atulbhai Shah has been appointed as the Internal Auditor of the company for the financial year 2026-27. M/s SPANJ & Associates has been appointed as the Secretarial Auditor for a period of five consecutive years from 2026-27 to 2030-31. Result PDF

• Trendlyne
• 4 weeks 1 day ago